UNSPSC 51285310: Nifuradene

This classification denotes a topical anti-infective agent with the molecular formula C8H8N4O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2VX65207DR, chemically known as 2-imidazolidinone, 1-(5-nitrofurfurylideneamino)- but more generally known as nifuradene, which bears US NIH Compound Identifier 11154. European Medicines Agency schedules Nifuradene in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09258MIG.

UNSPSC 51285310 Nifuradene is a Commodity code for a specific pharmaceutical active ingredient, but the recent state and local contract opportunities tagged under this code do not reflect nifuradene procurement. Instead, the opportunities show purchases of distinct pharmaceutical products — antibiotic tablets (doxycycline and ciprofloxacin) and emergency response medications (naloxone) — indicating a mismatch between the code designation and the work actually being solicited. State and local health departments and county public health agencies are using this code to tag pharmaceutical supply contracts, but the products named in recent solicitations fall outside nifuradene's specific scope.

Activity under this code shows minimal relevant recent purchasing. The Illinois Department of Public Health completed an award to Chartwell Rx LLC on August 28, 2026, for antibiotic supply through the MMCAP Infuse cooperative purchasing vehicle, totaling $2,999,999.11 over three years; Seminole County, Florida issued an IFB on June 30, 2026, for naloxone and drug deactivation systems with quarterly deliveries to its Community Health Building. The geographic spread is limited to Illinois and Florida in the recent record. Given the mismatch between the nifuradene commodity code and the pharmaceutical products actually being purchased in these solicitations, this code does not appear to reflect active nifuradene procurement at the state and local level.